Minocycline-induced autoimmune syndromes: an overview

O Elkayam, M Yaron, D Caspi - Seminars in arthritis and rheumatism, 1999 - Elsevier
OBJECTIVES: To increase awareness of minocycline-induced autoimmune syndromes.
METHODS: Review of relevant publications from the American and Europeanliterature. …

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 …

…, K Warnatz, NM Wulffraat, S Van Assen, O Elkayam - RMD open, 2019 - rmdopen.bmj.com
Aim To present a systematic literature review (SLR) on efficacy, immunogenicity and safety
of vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD), …

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review …

…, J Walker, K Warnatz, NM Wulffraat, O Elkayam - RMD open, 2019 - rmdopen.bmj.com
Objectives The aims of this study were to update the evidence on the incidence and prevalence
rates of vaccine preventable infections (VPI) in patients with autoimmune inflammatory …

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general …

…, O Sharon, S Pel, S Nevo, O Elkayam - Annals of the …, 2021 - ard.bmj.com
Introduction Vaccination represents a cornerstone in mastering the COVID-19 pandemic.
Data on immunogenicity and safety of messenger RNA (mRNA) vaccines in patients with …

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

…, K Warnatz, NM Wulffraat, O Elkayam - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for vaccination
in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) published …

Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series

…, A Kibari, D Rimar, Y Paran, O Elkayam - …, 2021 - academic.oup.com
Objectives As global vaccination campaigns against COVID-19 disease commence, vaccine
safety needs to be closely assessed. The safety profile of mRNA-based vaccines in patients …

Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFα blockers

…, I Wigler, E Mendelson, O Elkayam - Annals of the …, 2006 - ard.bmj.com
Objective: To assess the efficacy and safety of vaccination against influenza virus in patients
with rheumatoid arthritis, with special emphasis on the effect of disease modifying …

EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November …

…, B Combe, R Conway, JR Curtis, O Elkayam… - Annals of the …, 2022 - ard.bmj.com
The first EULAR provisional recommendations on the management of rheumatic and
musculoskeletal diseases (RMDs) in the context of severe acute respiratory syndrome coronavirus …

Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response

…, A Balbir-Gurman, D Caspi, O Elkayam - Annals of the …, 2008 - ard.bmj.com
Objective: To assess the effect of rituximab on the efficacy and safety of influenza virus vaccine
in patients with rheumatoid arthritis (RA). Methods: The study group comprised patients …

Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis

…, I Wigler, D Levartovsky, S Berliner, O Elkayam - Seminars in arthritis and …, 2007 - Elsevier
OBJECTIVES: To evaluate the extent of subclinical atherosclerosis by measuring the intima-media
wall thickness (IMT) of the common carotid artery in patients with psoriatic arthritis (…